10 kHz高频脊髓电刺激治疗慢性神经病理性下背痛的多中心双盲随机假对照试验方案
该方案针对未接受脊柱手术的慢性神经病理性下背痛(CNLBP)患者,计划纳入96例植入硬膜外电极和假电极者,随机1:1接受10 kHz脊髓电刺激(SCS)加常规护理或假刺激加常规护理。主要结局为7天疼痛日记,评估6个月时临床与成本效果,以指导该人群的SCS应用决策。
要点
- 研究纳入未手术的CNLBP患者,随机分组比较10 kHz SCS与假刺激的疗效。
- 主要结局为7天疼痛日记,次要结局包括ODI、并发症、EQ-5D-5L及成本。
- 6个月时分析组间差异并调整基线评分,计算每QALY增量成本。
核心结论
- 该试验将评估10 kHz SCS对未手术CNLBP患者的临床与成本效果,结果可为临床实践和卫生政策提供依据。
研究设计与样本
- 多中心、双盲、随机、假对照试验,并行经济评价,计划纳入96例未接受脊柱手术的CNLBP患者。
- 患者植入硬膜外电极和硬膜外间隙外的假电极,无筛选试验,随机1:1分至10 kHz SCS加常规护理组或假10 kHz SCS加常规护理组。
关键数值与推荐
- 主要结局为7天每日疼痛日记,在基线(随机前)及设备激活后1、3、6个月评估。
- 次要结局包括Oswestry功能障碍指数、并发症、EQ-5D-5L及健康和社会护理成本。
- 主要分析比较6个月时组间主要和次要结局,并调整基线结局评分;计算6个月及终生每质量调整生命年(QALY)增量成本。
临床怎么用
- 若试验证实有效,10 kHz SCS或可成为未手术CNLBP患者的治疗选择,并影响卫生资源配置。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Chronic neuropathic low back pain (CNLBP) is a debilitating condition in which established medical treatments seldom alleviate symptoms. Evidence demonstrates that high-frequency 10 kHz spinal cord stimulation (SCS) reduces pain and improves health-related quality of life in patients with failed back surgery syndrome (FBSS), but evidence of this effect is limited in individuals with CNLBP who have not had surgery. The aim of this multicentre randomised trial is to assess the clinical and cost-effectiveness of 10 kHz SCS for this population. METHODS: This is a multicentre, double-blind, randomised, sham-controlled trial with a parallel economic evaluation. A total of 96 patients with CNLBP who have not had spinal surgery will be implanted with an epidural lead and a sham lead outside the epidural space without a screening trial. Patients will be randomised 1:1 to 10 kHz SCS plus usual care (intervention group) or to sham 10 kHz SCS plus usual care (control group) after receiving the full implant. The SCS devices will be programmed identically using a cathodal cascade. Participants will use their handheld programmer to alter the intensity of the stimulation as per routine practice. The primary outcome will be a 7-day daily pain diary. Secondary outcomes include the Oswestry Disability Index, complications, EQ-5D-5 L, and health and social care costs. Outcomes will be assessed at baseline (pre-randomisation) and at 1 month, 3 months and 6 months after device activation. The primary analyses will compare primary and secondary outcomes between groups at 6 months, while adjusting for baseline outcome scores. Incremental cost per quality-adjusted life year (QALY) will be calculated at 6 months and over the lifetime of the patient. DISCUSSION: The outcomes of this trial will inform clinical practice and healthcare policy on the role of high-frequency 10 kHz SCS for use in patients with CNLBP who have not had surgery. TRIAL REGISTRATION: Clinicaltrials.gov, NCT03470766. Registered on 20 March 2018. DISCLAIMER: The views expressed here are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The NIHR had no role in the study design, writing of the manuscript or the decision to submit for publication. ROLES AND RESPONSIBILITIES: AK, SP, DP, SW, RST, AC, SE, LM, RD and JF all contributed to the trial design and to securing trial funding. AK, JR, SP, DP, and SE are involved in the recruitment, the intervention and the follow-up. SW will perform data collection and analysis. RST will be responsible for the statistical analysis, and RD will be responsible for the health economic analysis. All authors read and approved the final manuscript.
引用
- Al-Kaisy A, Royds J, Palmisani S, et al. Multicentre, double-blind, randomised, sham-controlled trial of 10 khz high-frequency spinal cord stimulation for chronic neuropathic low back pain (MODULATE-LBP): a trial protocol. Trials. 2020. PMID: 31992344. doi:10.1186/s13063-019-3831-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。